Search
Confirm
Cancel
News

News

Fusen Pharmaceutical Stock code:1652.HK
Location:
Homepage
-
-
-
Good news! Fusen pharmaceutical is listed as "top 50 Nanyang enterprises in 2021"!

Good news! Fusen pharmaceutical is listed as "top 50 Nanyang enterprises in 2021"!

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2021-11-10
  • Views:

(Summary description)On November 9, Nanyang Enterprise Federation and Entrepreneur Association released the list of "top 50 Nanyang enterprises in 2021" and the list of top 30 Nanyang high growth enterprises in 2021. Henan Fusen Industrial Group Co., Ltd. was listed as "top 50 Nanyang enterprises in 2021".

Good news! Fusen pharmaceutical is listed as "top 50 Nanyang enterprises in 2021"!

(Summary description)On November 9, Nanyang Enterprise Federation and Entrepreneur Association released the list of "top 50 Nanyang enterprises in 2021" and the list of top 30 Nanyang high growth enterprises in 2021. Henan Fusen Industrial Group Co., Ltd. was listed as "top 50 Nanyang enterprises in 2021".

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2021-11-10 17:11
  • Views:
Information

On November 9, Nanyang Enterprise Federation and Entrepreneur Association released the list of "top 50 Nanyang enterprises in 2021" and the list of top 30 Nanyang high growth enterprises in 2021. Henan Fusen Industrial Group Co., Ltd. was listed as "top 50 Nanyang enterprises in 2021".

As the "barometer" and "wind vane" of enterprise development in Nanyang City, the "top 50 list of Nanyang enterprises" has been released for 16 consecutive years, which is in line with the ranking and release of top 500 Chinese enterprises by China Enterprise Federation and top 100 Henan enterprises by Henan Enterprise Federation.

This ranking is calculated by the Municipal Enterprise Federation and entrepreneur association in accordance with the internationally accepted way and with reference to the specific practices of the state and Henan Province, taking the enterprise operating income (sales income) in 2020 as the shortlisted standard. This listing not only demonstrates the development ability of Fusen industrial group to keep pace with the times and forge ahead, but also reflects the lofty pattern and strategic determination of the group to start business in a down-to-earth and steady way.

Adhering to integrity and innovation and winning many honors

▲ Fusen pharmaceutical headquarters

In recent years, as the hometown of Zhang Zhongjing, the ancestral hall of traditional Chinese medicine and one of the birthplaces of traditional Chinese medicine civilization, Nanyang has always adhered to the concept of integrity, innovation and inheritance, attached great importance to the development of traditional Chinese medicine industry, and successively issued a number of support measures and development plans to promote the high-quality development of traditional Chinese medicine industry. As one of the leading enterprises of traditional Chinese medicine in Nanyang City, Fusen pharmaceutical has increasingly shown a vigorous development trend with the policy support of Nanyang Municipal government. It has won the titles of "national leading enterprise of agricultural industrialization" and "excellent private enterprise" and "high-tech enterprise" in Henan Province.

Build a planting base to ensure the quality of traditional Chinese Medicine

▲ gap planting base of traditional Chinese medicine of Fusen pharmaceutical

Henan Fusen Industrial Group Co., Ltd. is located in Xichuan County, Nanyang City, Henan Province, the main water source and canal head of the middle route of the South-to-North Water Transfer Project. Fusen Pharmaceutical Co., Ltd., the core subsidiary of the group, is a modern comprehensive pharmaceutical enterprise integrating herbal medicine planting, drug R & D, production and sales.

In order to ensure the quality of a series of products of Fusen pharmaceutical from the source, Fusen has established its own gap planting base of traditional Chinese medicine and takes the planting and processing of traditional Chinese medicine as the "first workshop" of production. At present, Fusen pharmaceutical has its own honeysuckle planting base of 30000 mu in Xichuan County, Scutellaria planting base of 20000 mu, forsythia base of 100000 mu in Jiang County, Shanxi Province, and a modern Chinese herbal medicine processing center.

Build a healthy China through years of strength precipitation

▲ Fusen pharmaceutical is listed in Hong Kong

Since its establishment in 2003, Fusen pharmaceutical has always adhered to the concept of "honesty and trustworthiness, strengthening the foundation, winning the brand and steady development", deeply cultivated in Henan and distributed throughout the country. Since it was listed on the main board of the Hong Kong Stock Exchange in 2018 (Stock Code: 1652. HK), the new journey of nationalization of Fusen pharmaceutical has been steadily promoted. In the future, under the background of healthy China, Fusen pharmaceutical will adhere to the business philosophy of "ingenuity, quality, health is happiness" to protect the health of consumers.

Related News

Fusen

Fusen pharmaceutical: metformin hydrochloride sustained release tablets passed the consistency evaluation

Fusen pharmaceutical metformin hydrochloride sustained-release tablets have successfully passed the evaluation of the consistency of quality and efficacy of generic drugs! Metformin Hydrochloride Sustained Release Tablets, a diabetes drug, has been approved by the State Administration for drug control. This product has successfully passed the quality and efficacy consistency evaluation of generic drugs, which is an authoritative recognition of the R & D capacity, production and quality management system and clinical efficacy of Fusen pharmaceutical, further highlights the product brand of Fusen pharmaceutical, helps to improve the market competitiveness of the drug, and accumulates valuable experience for the company's follow-up products to carry out generic drug consistency evaluation. ▲ notice of approval from the State Drug Administration Metformin Hydrochloride Tablets is the basic medicine for diabetes. It is used for diet and physical exercise to control type 2 diabetes patients with blood glucose inefficacy, especially obesity and hyperinsulinemia. As a first-line drug for the treatment of type II diabetes, metformin is often used in combination with other oral hypoglycemic agents. ▲ for medical professionals only Because of the superiority of metformin, it is listed as the first-line treatment for hypoglycemic treatment in the guidelines for prevention and treatment of type II diabetes, formulated by professional academic organizations both at home and abroad. As the holder of drug marketing license, Fusen pharmaceutical will not forget its original intention, forge ahead, strictly control the product quality, and constantly optimize the product layout, so that more drugs of Fusen pharmaceutical can benefit the majority of patients.
2022-04-26
Jiaheng

Jiaheng pharmaceutical was approved to set up a post doctoral research workstation sub station

Recently, the Department of human resources and social security of Guangdong Province issued a notice that the National Postdoctoral Management Committee approved Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of Fusen pharmaceutical, to set up a postdoctoral scientific research workstation branch. ▲ exhibition hall of Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd ▲ exhibition hall of Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd. is a research and development subsidiary established by Fusen pharmaceutical in response to the national development strategy of traditional Chinese medicine. In order to enhance the independent research and development ability of traditional Chinese medicine, take the research and development of high-quality and effective traditional Chinese medicine as the main goal, and integrate the high-quality traditional Chinese medicine resources in the industry. ▲ Guangdong Macao science and Technology Industrial Park of traditional Chinese Medicine The company is located in Hengqin Guangdong Macao cooperative traditional Chinese medicine science and Technology Industrial Park. It is the first R & D platform settled in the industrial park and officially operated after the establishment of Hengqin Guangdong Macao deep cooperation zone. It is the supporting unit of the large variety cultivation sub center of traditional Chinese medicine of the national traditional Chinese medicine modernization engineering technology center. Its main business is the R & D of innovative traditional Chinese medicine and secondary development of traditional Chinese medicine, chemical medicine raw materials and preparations, light medicine and beauty products and great health products. This time, Jiaheng pharmaceutical was approved to set up a post doctoral research workstation sub station, which is an affirmation of Jiaheng pharmaceutical's technological innovation ability and R & D ability, creates conditions for the company's talent training and the improvement of technological innovation ability, is conducive to further promoting the company's cooperation with universities and scientific research institutes, is conducive to the introduction of high-end R & D talents, is conducive to further improving the company's independent R & D ability and realizing the landing and transformation of scientific research achievements, Promote the sustainable innovation and development of the company and continuously improve the core competitiveness of the company.
2022-04-19

WeChat

福森药业

Copyright © 2021 Fusen Pharmaceutical Company Limited

豫ICP备2021028871号  Powered by www.300.cn

Copyright © 2021 Fusen Pharmaceutical  All Rights Reserved.      豫ICP备2021028871号        Powered by www.300.cn